Label Changes for:

Viread (tenofovir disoproxil fumarate) Oral Powder, 40 mg/gram

July 2013

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

July 2013

ADVERSE REACTIONS

Drug Interactions
  • In patients weighing less than 60 kg, the didanosine dose should be reduced to 200 mg once daily when it is coadministered with VIREAD
     
Hide
(web2)